Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients

  1. Bandres, E.
  2. Rodriguez, J.
  3. Hernandez, A.
  4. Bitarte, N.
  5. Ramirez, N.
  6. Diaz-Gonzalez, J. A.
  7. Chopitea, A.
  8. Ponz, M.
  9. Zarate, R. N.
  10. Garcia-Foncillas, J.
Zeitschrift:
EJC SUPPLEMENTS

ISSN: 1359-6349

Datum der Publikation: 2009

Ausgabe: 7

Nummer: 2

Seiten: 113-113

Kongress: 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology

Art: Konferenz-Beitrag

DOI: 10.1016/S1359-6349(09)70388-X GOOGLE SCHOLAR
Fuente de los datos: WoS